SCH-50971
| Clinical data | |
|---|---|
| Other names | Sch-50971 |
| Routes of administration | Oral |
| Drug class | Histamine H3 receptor agonist |
| ATC code |
|
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C8H13N3 |
| Molar mass | 151.213 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
SCH-50971 is a histamine H3 receptor agonist which was under development for the treatment of anxiety disorders, gastrointestinal disorders, and migraine but was never marketed.